#ariba_ref_name	ref_name	gene	var_only	flag	reads	cluster	ref_len	ref_base_assembled	pc_ident	ctg	ctg_len	ctg_cov	known_var	var_type	var_seq_type	known_var_change	has_known_var	ref_ctg_change	ref_ctg_effect	ref_start	ref_end	ref_nt	ctg_start	ctg_end	ctg_nt	smtls_total_depth	smtls_nts	smtls_nts_depth	var_description	free_text
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	531	11698	16S	1529	1529	99.93	16S.l15.c4.ctg.1	2019	576.3	0	.	n	.	0	C1450T	SNP	1450	1450	C	1694	1694	T	646	T	592	.	.
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	531	11698	16S	1529	1529	99.93	16S.l15.c4.ctg.1	2019	576.3	1	SNP	n	C1184T	0	.	.	1184	1184	C	1428	1428	C	682	C,A	636,1	16S.rDNA_WHO_F_01361c:0:1:C1184T:16S.1184T:E coli C1192T. Resistance to Spectinomycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	21806	23S	2890	2890	99.93	23S.l6.c30.ctg.1	3585	606.6	0	.	n	.	0	G1337A	SNP	1337	1337	G	1649	1649	A	727	A	677	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	21806	23S	2890	2890	99.93	23S.l6.c30.ctg.1	3585	606.6	0	.	n	.	0	T1971C	SNP	1971	1971	T	2283	2283	C	700	C,G	638,1	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	21806	23S	2890	2890	99.93	23S.l6.c30.ctg.1	3585	606.6	1	SNP	n	A2045G	0	.	.	2045	2045	A	2357	2357	A	657	A	618	23S.rDNA_WHO_F_01358c:0:1:A2045G:23S.2045G:E coli A2059G. High-level resistance to Azithromycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	21806	23S	2890	2890	99.93	23S.l6.c30.ctg.1	3585	606.6	1	SNP	n	C2597T	0	.	.	2597	2597	C	2909	2909	C	666	C	625	23S.rDNA_WHO_F_01358c:0:1:C2597T:23S.2597T :E coli C2611T. Low-level resistance to Azithromycin	.
blaTEM.WHO_M_pConjugative_00003	blaTEM.WHO_M_pConjugative_00003	1	0	27	53062	blaTEM	861	861	100.0	blaTEM.l15.c4.ctg.1	1684	3144.1	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Betalactam resistance
folP.WHO_L_00516	folP.WHO_L_00516	1	1	539	1686	folP	855	855	99.88	folP.l6.c30.ctg.1	1471	114.1	1	SNP	p	R229S	1	R229S	NONSYN	685	687	CGC	961	963	AGC	156;157;155	A;G;C	144;147;144	folP.WHO_L_00516:1:1:R229S:folP.228S:Resistance to sulphonamides	.
gyrA.WHO_G_01105	gyrA.WHO_G_01105	1	1	539	4416	gyrA	2751	2751	99.96	gyrA.l6.c30.ctg.1	3331	132.2	0	.	p	.	0	D95A	NONSYN	283	285	GAC	577	579	GCC	133;131;132	G;C;C	122;119;118	.	.
gyrA.WHO_G_01105	gyrA.WHO_G_01105	1	1	539	4416	gyrA	2751	2751	99.96	gyrA.l6.c30.ctg.1	3331	132.2	1	SNP	p	S91F	1	.	.	271	273	TTC	565	567	TTC	137;137;136	T;T;C	123;126;125	gyrA.WHO_G_01105:1:1:S91F:gyrA.91F:Resistance to fluoroquinolones	.
mtrR.WHO_O_01438	mtrR.WHO_O_01438	1	1	531	1342	mtrR	633	633	99.06	mtrR.l15.c4.ctg.1	1255	106.4	0	.	p	.	0	A39T	NONSYN	115	117	GCC	441	443	ACC	169;170;165	A,G;C;C	155,1;157;153	.	.
mtrR.WHO_O_01438	mtrR.WHO_O_01438	1	1	531	1342	mtrR	633	633	99.06	mtrR.l15.c4.ctg.1	1255	106.4	0	.	p	.	0	Y105H	NONSYN	313	315	TAC	639	641	CAC	184;185;184	C;A;C	169;168;168	.	.
mtrR.WHO_O_01438	mtrR.WHO_O_01438	1	1	531	1342	mtrR	633	633	99.06	mtrR.l15.c4.ctg.1	1255	106.4	0	.	p	.	0	A127fs	FSHIFT	379	379	G	705	705	G	168	GCCCC,GCC	159,1	.	.
mtrR.WHO_O_01438	mtrR.WHO_O_01438	1	1	531	1342	mtrR	633	633	99.06	mtrR.l15.c4.ctg.1	1255	106.4	1	SNP	p	G45D	0	.	.	133	135	GGC	459	461	GGC	174;173;174	G;G;C	156;156;156	mtrR.WHO_O_01438:1:1:G45D:mtrR.45D:Increased efflux of antimicrobials, e.g. macrolides and b-lactam antimicrobials, that are substrates of the MtrCDE efflux pump	.
mtrR_promoter.WHO_F	mtrR_promoter.WHO_F	0	0	19	634	mtrR_promoter	250	250	100.0	mtrR_promoter.l15.c4.ctg.1	871	72.1	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.
parC.WHO_F_01444	parC.WHO_F_01444	1	1	539	3948	parC	2304	2304	99.65	parC.l15.c17.ctg.1	2926	134.1	0	.	p	.	0	S87N	NONSYN	259	261	AGT	640	642	AAT	158;157;153	A;A;T	146;146;142	.	.
parC.WHO_F_01444	parC.WHO_F_01444	1	1	539	3948	parC	2304	2304	99.65	parC.l15.c17.ctg.1	2926	134.1	0	.	p	.	0	E91K	NONSYN	271	273	GAG	652	654	AAG	149;148;145	A;A;G	138;138;136	.	.
parC.WHO_F_01444	parC.WHO_F_01444	1	1	539	3948	parC	2304	2304	99.65	parC.l15.c17.ctg.1	2926	134.1	0	.	p	.	0	V435A	NONSYN	1303	1305	GTG	1684	1686	GCA	161;164;166	G;C,T;A	138;135,1;142	.	.
parC.WHO_F_01444	parC.WHO_F_01444	1	1	539	3948	parC	2304	2304	99.65	parC.l15.c17.ctg.1	2926	134.1	1	SNP	p	D86N	0	.	.	256	258	GAC	637	639	GAC	159;160;159	G;A;C	146;147;146	parC.WHO_F_01444:1:1:D86N:parC.86N:Resistance to fluoroquinolones	.
parC.WHO_F_01444	parC.WHO_F_01444	1	1	539	3948	parC	2304	2304	99.65	parC.l15.c17.ctg.1	2926	134.1	1	SNP	p	S88P	0	.	.	262	264	TCC	643	645	TCC	153;152;149	T;C;C	143;142;143	parC.WHO_F_01444:1:1:S88P:parC.88P:Resistance to fluoroquinolones	.
parE.WHO_F_01528c	parE.WHO_F_01528c	1	1	27	3482	parE	1986	1986	99.95	parE.l15.c4.ctg.1	2667	130.1	1	SNP	p	G410V	0	.	.	1228	1230	GGC	1511	1513	GGC	176;173;171	G;G;C	159;158;156	parE.WHO_F_01528c:1:1:G410V:parE.410V:Resistance to fluoroquinolones	.
penA.19.001	penA.19.001	1	1	27	3232	penA	1752	1752	100.0	penA.l15.c4.ctg.1	2352	137.0	1	SNP	p	A311V	0	.	.	931	933	GCA	1197	1199	GCA	184;184;187	G,T;C;A	168,1;168;172	penA.19.001:1:1:A311V:penA.311V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.19.001	penA.19.001	1	1	27	3232	penA	1752	1752	100.0	penA.l15.c4.ctg.1	2352	137.0	1	SNP	p	I312M	0	.	.	934	936	ATC	1200	1202	ATC	188;191;190	A;T;C	173;175;172	penA.19.001:1:1:I312M:penA.312M:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.19.001	penA.19.001	1	1	27	3232	penA	1752	1752	100.0	penA.l15.c4.ctg.1	2352	137.0	1	SNP	p	V316T	0	.	.	946	948	GTG	1212	1214	GTG	189;186;186	G;T;G	178;177;177	penA.19.001:1:1:V316T:penA.316T:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.19.001	penA.19.001	1	1	27	3232	penA	1752	1752	100.0	penA.l15.c4.ctg.1	2352	137.0	1	SNP	p	V316P	0	.	.	946	948	GTG	1212	1214	GTG	189;186;186	G;T;G	178;177;177	penA.19.001:1:1:V316P:penA.316P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.19.001	penA.19.001	1	1	27	3232	penA	1752	1752	100.0	penA.l15.c4.ctg.1	2352	137.0	1	SNP	p	T484S	0	.	.	1450	1452	ACC	1716	1718	ACC	194;192;192	A;C;C	167;171;170	penA.19.001:1:1:T484S:penA.483S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.19.001	penA.19.001	1	1	27	3232	penA	1752	1752	100.0	penA.l15.c4.ctg.1	2352	137.0	1	SNP	p	A502V	0	.	.	1504	1506	GCG	1770	1772	GCG	174;170;168	G,T;C;G,A	147,1;130;145,1	penA.19.001:1:1:A502V:penA.501V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.19.001	penA.19.001	1	1	27	3232	penA	1752	1752	100.0	penA.l15.c4.ctg.1	2352	137.0	1	SNP	p	A502P	0	.	.	1504	1506	GCG	1770	1772	GCG	174;170;168	G,T;C;G,A	147,1;130;145,1	penA.19.001:1:1:A502P:penA.501P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.19.001	penA.19.001	1	1	27	3232	penA	1752	1752	100.0	penA.l15.c4.ctg.1	2352	137.0	1	SNP	p	G543S	0	.	.	1627	1629	GGT	1893	1895	GGT	165;164;164	G;G;T	145;144;143	penA.19.001:1:1:G543S:penA.542S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.19.001	penA.19.001	1	1	27	3232	penA	1752	1752	100.0	penA.l15.c4.ctg.1	2352	137.0	1	SNP	p	G546S	0	.	.	1636	1638	GGC	1902	1904	GGC	159;160;159	G;G;C	143;142;141	penA.19.001:1:1:G546S:penA.545S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.19.001	penA.19.001	1	1	27	3232	penA	1752	1752	100.0	penA.l15.c4.ctg.1	2352	137.0	1	SNP	p	P552S	0	.	.	1654	1656	CCG	1920	1922	CCG	135;139;137	C,G;C,G;G	96,2;104,1;102	penA.19.001:1:1:P552S:penA.551S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
ponA.WHO_G_00106	ponA.WHO_G_00106	1	1	27	4630	ponA	2397	2397	100.0	ponA.l15.c4.ctg.1	3063	150.6	1	SNP	p	L421P	1	.	.	1261	1263	CCG	1601	1603	CCG	188;188;188	C;C;G	163;169;164	ponA.WHO_G_00106:1:1:L421P:ponA.421P:High-level chromosomally-mediated penicillin resistance	.
porA.NCCP11945	porA.NCCP11945	1	0	531	1822	porA	1146	1146	99.65	porA.l6.c17.ctg.1	1581	114.4	0	.	p	.	0	M83fs	FSHIFT	247	247	A	462	462	C	123	C	113	.	.
porB1a.WHO_F_02106	porB1a.WHO_F_02106	1	0	528	256	porB1a	984	271	92.25	porB1a.l15.c30.ctg.2	331	28.6	0	.	p	.	0	V258L	NONSYN	772	774	GTA	98	100	TTA	53;53;53	T,G;T;A	46,1;48;48	.	.
porB1a.WHO_F_02106	porB1a.WHO_F_02106	1	0	528	256	porB1a	984	271	92.25	porB1a.l15.c30.ctg.2	331	28.6	0	.	p	.	0	Y273H	NONSYN	817	819	TAT	143	145	CAT	50;47;44	C;A;T	44;43;41	.	.
porB1a.WHO_F_02106	porB1a.WHO_F_02106	1	0	528	256	porB1a	984	271	92.25	porB1a.l15.c30.ctg.2	331	28.6	0	.	p	.	0	D274S	NONSYN	820	822	GAT	146	148	AGT	44;44;45	A;G;T	41;41;41	.	.
porB1a.WHO_F_02106	porB1a.WHO_F_02106	1	0	528	256	porB1a	984	271	92.25	porB1a.l15.c30.ctg.2	331	28.6	0	.	p	.	0	N277Y	NONSYN	829	831	AAC	155	157	TAC	48;48;49	T;A;C	42;41;43	.	.
porB1a.WHO_F_02106	porB1a.WHO_F_02106	1	0	528	256	porB1a	984	271	92.25	porB1a.l15.c30.ctg.2	331	28.6	0	.	p	.	0	R307E	NONSYN	919	921	AGA	245	247	GAA	12;12;12	G;A;A	12;12;12	.	.
porB1a.WHO_F_02106	porB1a.WHO_F_02106	1	0	528	256	porB1a	984	271	92.25	porB1a.l15.c30.ctg.2	331	28.6	0	.	p	.	0	T311A	NONSYN	931	933	ACA	257	259	GCA	9;9;9	G;C;A	9;9;9	.	.
porB1a.WHO_F_02106	porB1a.WHO_F_02106	1	0	528	256	porB1a	984	271	92.25	porB1a.l15.c30.ctg.2	331	28.6	0	.	p	.	0	F314I	NONSYN	940	942	TTC	266	268	ATC	9;9;9	A;T;C	9;9;9	.	.
porB1a.WHO_F_02106	porB1a.WHO_F_02106	1	0	528	256	porB1a	984	271	92.25	porB1a.l15.c30.ctg.2	331	28.6	0	.	p	.	0	A316S	NONSYN	946	948	GCG	272	274	TCG	8;8;8	T;C;G	8;8;8	.	.
porB1a.WHO_F_02106	porB1a.WHO_F_02106	1	0	528	256	porB1a	984	271	92.25	porB1a.l15.c30.ctg.2	331	28.6	0	.	p	.	0	V318A	NONSYN	952	954	GTC	278	280	GCC	8;7;7	G;C;C	8;7;7	.	.
porB1a.WHO_F_02106	porB1a.WHO_F_02106	1	0	528	256	porB1a	984	271	92.25	porB1a.l15.c30.ctg.2	331	28.6	0	.	p	.	0	G319S	NONSYN	955	957	GGC	281	283	AGC	7;8;8	A;G;C	7;7;7	.	.
porB1a.WHO_F_02106	porB1a.WHO_F_02106	1	0	528	256	porB1a	984	271	92.25	porB1a.l15.c30.ctg.2	331	28.6	0	.	p	.	0	G320A	NONSYN	958	960	GGT	284	286	GCC	8;8;8	G;C;C	7;8;7	.	.
porB1a.WHO_F_02106	porB1a.WHO_F_02106	1	0	528	256	porB1a	984	271	92.25	porB1a.l15.c30.ctg.2	331	28.6	0	.	p	.	0	G322V	NONSYN	964	966	GGT	290	292	GTT	8;8;8	G;T;T	7;8;7	.	.
porB1b.WHO_U_02278c	porB1b.WHO_U_02278c	1	1	539	2290	porB1b	1035	1035	98.85	porB1b.l15.c4.ctg.1	1558	146.1	0	.	p	.	0	R40G	NONSYN	118	120	CGG	414	416	GGG	186;183;188	G;G;G	169;167;169	.	.
porB1b.WHO_U_02278c	porB1b.WHO_U_02278c	1	1	539	2290	porB1b	1035	1035	98.85	porB1b.l15.c4.ctg.1	1558	146.1	0	.	p	.	0	R143G	NONSYN	427	429	AGA	723	725	GGA	170;168;169	G;G;A,G	151;148;145,1	.	.
porB1b.WHO_U_02278c	porB1b.WHO_U_02278c	1	1	539	2290	porB1b	1035	1035	98.85	porB1b.l15.c4.ctg.1	1558	146.1	0	.	p	.	0	.	INDELS	629	630	AA	926	928	TAG	201;199;200	T;A;G	188;187;184	.	.
porB1b.WHO_U_02278c	porB1b.WHO_U_02278c	1	1	539	2290	porB1b	1035	1035	98.85	porB1b.l15.c4.ctg.1	1558	146.1	0	.	p	.	0	.	MULTIPLE	631	633	TAC	930	933	CAAT	200;201;203;202	C;A;A;T	182;185;187;187	.	.
porB1b.WHO_U_02278c	porB1b.WHO_U_02278c	1	1	539	2290	porB1b	1035	1035	98.85	porB1b.l15.c4.ctg.1	1558	146.1	0	.	p	.	0	N212fs	FSHIFT	634	634	A	935	935	T	204	T	191	.	.
porB1b.WHO_U_02278c	porB1b.WHO_U_02278c	1	1	539	2290	porB1b	1035	1035	98.85	porB1b.l15.c4.ctg.1	1558	146.1	1	SNP	p	G120K	0	.	.	358	360	GGT	654	656	GGT	161;159;159	G;G;T	148;149;146	porB1b.WHO_U_02278c:1:1:G120K:porB1b.120K:G101K. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_U_02278c	porB1b.WHO_U_02278c	1	1	539	2290	porB1b	1035	1035	98.85	porB1b.l15.c4.ctg.1	1558	146.1	1	SNP	p	A121D	0	.	.	361	363	GCC	657	659	GCC	158;158;157	G;C;C	145;149;149	porB1b.WHO_U_02278c:1:1:A121D:porB1b.121D:A102D. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_U_02278c	porB1b.WHO_U_02278c	1	1	539	2290	porB1b	1035	1035	98.85	porB1b.l15.c4.ctg.1	1558	146.1	1	SNP	p	A121N	0	.	.	361	363	GCC	657	659	GCC	158;158;157	G;C;C	145;149;149	porB1b.WHO_U_02278c:1:1:A121N:porB1b.121N:A102N. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
rpoB.WHO_F_02153c	rpoB.WHO_F_02153c	1	1	539	9036	rpoB	4179	4179	99.98	rpoB.l15.c30.ctg.1	4899	184.0	1	SNP	p	H553N	1	H553N	NONSYN	1657	1659	CAT	2011	2013	AAT	200;201;202	A;A;T	188;187;190	rpoB.WHO_F_02153c:1:1:H553N:rpoB.553N:H552N. High-level resistance to Rifampicin	.
rpsJ.WHO_Y_02241	rpsJ.WHO_Y_02241	1	1	27	948	rpsJ	312	312	100.0	rpsJ.l15.c30.ctg.1	907	103.4	1	SNP	p	V57M	1	.	.	169	171	ATG	492	494	ATG	192;187;185	A;T;G	173;171;170	rpsJ.WHO_Y_02241:1:1:V57M:rpsJ.57M:Chromosomally-mediated resistance to tetracyclines	.
tetM.WHO_G_pTetM_00047	tetM.WHO_G_pTetM_00047	1	0	539	8288	tetM	1920	1920	96.3	tetM.l15.c30.ctg.1	2615	316.6	0	.	p	.	0	M177T	NONSYN	529	531	ATG	924	926	ACG	341;339;335	A;C;G,T	322;323;319,1	.	Tetracycline resistance
tetM.WHO_G_pTetM_00047	tetM.WHO_G_pTetM_00047	1	0	539	8288	tetM	1920	1920	96.3	tetM.l15.c30.ctg.1	2615	316.6	0	.	p	.	0	Y184D	NONSYN	550	552	TAC	945	947	GAC	294;294;291	G,T;A;C	293,1;289;290	.	Tetracycline resistance
tetM.WHO_G_pTetM_00047	tetM.WHO_G_pTetM_00047	1	0	539	8288	tetM	1920	1920	96.3	tetM.l15.c30.ctg.1	2615	316.6	0	.	p	.	0	T190M	NONSYN	568	570	ACG	963	965	ATG	278;276;273	A;T;G	278;276;273	.	Tetracycline resistance
tetM.WHO_G_pTetM_00047	tetM.WHO_G_pTetM_00047	1	0	539	8288	tetM	1920	1920	96.3	tetM.l15.c30.ctg.1	2615	316.6	0	.	p	.	0	L194S	NONSYN	580	582	TTA	975	977	TCA	270;274;271	T;C;A	268;273;271	.	Tetracycline resistance
tetM.WHO_G_pTetM_00047	tetM.WHO_G_pTetM_00047	1	0	539	8288	tetM	1920	1920	96.3	tetM.l15.c30.ctg.1	2615	316.6	0	.	p	.	0	H209Q	NONSYN	625	627	CAT	1020	1022	CAG	275;274;274	C;A;G	268;267;265	.	Tetracycline resistance
tetM.WHO_G_pTetM_00047	tetM.WHO_G_pTetM_00047	1	0	539	8288	tetM	1920	1920	96.3	tetM.l15.c30.ctg.1	2615	316.6	0	.	p	.	0	V216L	NONSYN	646	648	GTT	1041	1043	CTT	259;258;254	C;T;T	255;254;250	.	Tetracycline resistance
tetM.WHO_G_pTetM_00047	tetM.WHO_G_pTetM_00047	1	0	539	8288	tetM	1920	1920	96.3	tetM.l15.c30.ctg.1	2615	316.6	0	.	p	.	0	N223S	NONSYN	667	669	AAC	1062	1064	AGT	256;260;269	A;G;T	247;250;254	.	Tetracycline resistance
tetM.WHO_G_pTetM_00047	tetM.WHO_G_pTetM_00047	1	0	539	8288	tetM	1920	1920	96.3	tetM.l15.c30.ctg.1	2615	316.6	0	.	p	.	0	Q246P	NONSYN	736	738	CAG	1131	1133	CCG	389;395;396	C;C;G,A	357;362;364,1	.	Tetracycline resistance
tetM.WHO_G_pTetM_00047	tetM.WHO_G_pTetM_00047	1	0	539	8288	tetM	1920	1920	96.3	tetM.l15.c30.ctg.1	2615	316.6	0	.	p	.	0	P280S	NONSYN	838	840	CCG	1233	1235	TCG	428;429;431	T;C,T;G,T	392;389,1;394,1	.	Tetracycline resistance
tetM.WHO_G_pTetM_00047	tetM.WHO_G_pTetM_00047	1	0	539	8288	tetM	1920	1920	96.3	tetM.l15.c30.ctg.1	2615	316.6	0	.	p	.	0	E337K	NONSYN	1009	1011	GAG	1404	1406	AAA	236;232;231	A;A;A	222;218;217	.	Tetracycline resistance
tetM.WHO_G_pTetM_00047	tetM.WHO_G_pTetM_00047	1	0	539	8288	tetM	1920	1920	96.3	tetM.l15.c30.ctg.1	2615	316.6	0	.	p	.	0	R338K	NONSYN	1012	1014	AGA	1407	1409	AAG	229;227;219	A;A;G	216;216;209	.	Tetracycline resistance
tetM.WHO_G_pTetM_00047	tetM.WHO_G_pTetM_00047	1	0	539	8288	tetM	1920	1920	96.3	tetM.l15.c30.ctg.1	2615	316.6	0	.	p	.	0	L343H	NONSYN	1027	1029	CTC	1422	1424	CAC	186;187;183	C;A;C	186;180;183	.	Tetracycline resistance
tetM.WHO_G_pTetM_00047	tetM.WHO_G_pTetM_00047	1	0	539	8288	tetM	1920	1920	96.3	tetM.l15.c30.ctg.1	2615	316.6	0	.	p	.	0	Q356E	NONSYN	1066	1068	CAA	1461	1463	GAA	162;161;158	G;A;A	161;161;158	.	Tetracycline resistance
tetM.WHO_G_pTetM_00047	tetM.WHO_G_pTetM_00047	1	0	539	8288	tetM	1920	1920	96.3	tetM.l15.c30.ctg.1	2615	316.6	0	.	p	.	0	A382T	NONSYN	1144	1146	GCG	1539	1541	ACG	107;108;105	A;C;G	105;105;104	.	Tetracycline resistance
tetM.WHO_G_pTetM_00047	tetM.WHO_G_pTetM_00047	1	0	539	8288	tetM	1920	1920	96.3	tetM.l15.c30.ctg.1	2615	316.6	0	.	p	.	0	T399I	NONSYN	1195	1197	ACT	1590	1592	ATT	187;186;186	A;T;T	166;167;166	.	Tetracycline resistance
tetM.WHO_G_pTetM_00047	tetM.WHO_G_pTetM_00047	1	0	539	8288	tetM	1920	1920	96.3	tetM.l15.c30.ctg.1	2615	316.6	0	.	p	.	0	C400S	NONSYN	1198	1200	TGT	1593	1595	AGT	185;184;185	A;G;T	165;167;169	.	Tetracycline resistance
tetM.WHO_G_pTetM_00047	tetM.WHO_G_pTetM_00047	1	0	539	8288	tetM	1920	1920	96.3	tetM.l15.c30.ctg.1	2615	316.6	0	.	p	.	0	I413L	NONSYN	1237	1239	ATA	1632	1634	CTA	207;210;212	C,A;T;A,T	183,1;186;187,1	.	Tetracycline resistance
tetM.WHO_G_pTetM_00047	tetM.WHO_G_pTetM_00047	1	0	539	8288	tetM	1920	1920	96.3	tetM.l15.c30.ctg.1	2615	316.6	0	.	p	.	0	K427N	NONSYN	1279	1281	AAA	1674	1676	AAT	133;136;138	A;A;T,A	128;131;132,1	.	Tetracycline resistance
tetM.WHO_G_pTetM_00047	tetM.WHO_G_pTetM_00047	1	0	539	8288	tetM	1920	1920	96.3	tetM.l15.c30.ctg.1	2615	316.6	0	.	p	.	0	A450S	NONSYN	1348	1350	GCA	1743	1745	TCA	212;212;212	T,G;C;A	201,1;201;200	.	Tetracycline resistance
tetM.WHO_G_pTetM_00047	tetM.WHO_G_pTetM_00047	1	0	539	8288	tetM	1920	1920	96.3	tetM.l15.c30.ctg.1	2615	316.6	0	.	p	.	0	V458M	NONSYN	1372	1374	GTA	1767	1769	ATG	226;227;227	A;T;G	217;217;217	.	Tetracycline resistance
tetM.WHO_G_pTetM_00047	tetM.WHO_G_pTetM_00047	1	0	539	8288	tetM	1920	1920	96.3	tetM.l15.c30.ctg.1	2615	316.6	0	.	p	.	0	N556T	NONSYN	1666	1668	AAC	2061	2063	ACC	509;511;511	A;C;C	461;468;467	.	Tetracycline resistance
tetM.WHO_G_pTetM_00047	tetM.WHO_G_pTetM_00047	1	0	539	8288	tetM	1920	1920	96.3	tetM.l15.c30.ctg.1	2615	316.6	0	.	p	.	0	K588E	NONSYN	1762	1764	AAA	2157	2159	GAA	453;455;452	G;A;A	419;421;419	.	Tetracycline resistance
